EUVIMEDEUVIMED entdecken
Crossref

Physiotherapy in Juvenile Dermatomyositis

Theodora Polychronopoulou

Journal of Research and Practice on the Musculoskeletal System · 2017

DOI: 10.22540/jrpms-01-014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Research and Practice on the Musculoskeletal System, 2017. Verfasst von Theodora Polychronopoulou. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PathogenesisThe pathogenesis of JDM involves several infectious agents (coxsackie virus, Toxoplasma spp, echovirus, parvovirus) and environmental triggers (sun exposure, medications, and vaccines).A suggested possibility for the immune response is a molecular imitation 7 .In JDM patients, peripheral blood cells have been shown to lyse autologous target cells presenting a binding peptide derived from skeletal myosin.It has also been found that the amino acid sequence of Protein M5 of hemolytic Aβ group streptococci is homologous to the human skeletal heavy chain.So we can understand that the muscular fiber disaster can participate to these cytotoxic T lymphocytes and that the myosin heavy chain epitope may be a tee autoantigen in JDM.JDM basic characteristic is the skin and muscle vasculitis.There are several reports of various human Abstract Juvenile dermatomyositis (JDM) is a relatively rare, multi-systemic autoimmune disease, which combines inflammatory myopathy, characteristic cutaneous findings and symptoms of other organ systems.In JDM the basic characteristic is the skin and muscle vasculitis, although the first sign of JDM is usually a skin rash in a V-shaped pattern that may be red and patchy, with typically red or purplish color on the eyelids ("heliotrope" rash), cheeks, or both.The medications used for the relief of symptoms of dermatomyositis are corticosteroids, cyclosporine, intravenous immunoglobulin, cyclophosphamide, methotrexate, and biological agents.Evidence shows that children with low-activity dermatomyositis should be able to safely perform aerobic exercise and resistance-based exercise regimes to reduce disease activity and improve circulation in the resting phase, but also during exercise.Until now, both pharmaceutical therapy and physiotherapy have been proven the best way to treat the disease so that patients achieve complete remission without disease-related complications or any use of steroids.

Zitieren

APA

Polychronopoulou, T. (2017). Physiotherapy in Juvenile Dermatomyositis. Journal of Research and Practice on the Musculoskeletal System. https://doi.org/10.22540/jrpms-01-014

Vancouver

Polychronopoulou T. Physiotherapy in Juvenile Dermatomyositis. Journal of Research and Practice on the Musculoskeletal System. 2017. doi:10.22540/jrpms-01-014

BibTeX
@article{Polychronopoulou2017,
  author = {Polychronopoulou, Theodora},
  title = {Physiotherapy in Juvenile Dermatomyositis},
  journal = {Journal of Research and Practice on the Musculoskeletal System},
  year = {2017},
  doi = {10.22540/jrpms-01-014}
}
Kostenlos starten →